415P Patterns of Time-to-progression Intervals Across Clinical and Liquid Biopsy (LB) Features in Hormone Receptor-Positive (HR+) HER2-negative (HER2-) Metastatic Breast Cancer (MBC) Patients (pts) Treated with First-Line Endocrine Therapy (ET)
Annals of Oncology(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要